Related references
Note: Only part of the references are listed.Chymotrypsin-like activity and subunit composition of proteasomes in human cancers
I. V. Kondakova et al.
MOLECULAR BIOLOGY (2014)
Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia
X-W Yang et al.
ONCOGENE (2014)
Changes in Proteasome Chymotrypsin-Like Activity during the Development of Human Mammary and Thyroid Carcinomas
E. E. Shashova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
Role of microRNAs in breast cancer
Ramesh Singh et al.
CANCER BIOLOGY & THERAPY (2013)
A novel role of EMMPRIN/CD147 in transformation of quiescent fibroblasts to cancer-associated fibroblasts by breast cancer cells
Jing Xu et al.
CANCER LETTERS (2013)
MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer
Neha Nagpal et al.
CARCINOGENESIS (2013)
Expression of vascular endothelial growth factor and transcription factors HIF-1, NF-kB expression in squamous cell carcinoma of head and neck; association with proteasome and calpain activities
Liudmila V. Spirina et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
Gianpiero Di Leva et al.
PLOS GENETICS (2013)
Emerging Roles of the Ubiquitin-Proteasome System in the Steroid Receptor Signaling
Jung Hoon Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Association of growth factors, HIF-1 and NF-κB expression with proteasomes in endometrial cancer
Ludmila V. Spirina et al.
MOLECULAR BIOLOGY REPORTS (2012)
Proteasome Activity in Tumors of the Female Reproductive System
I. V. Kondakova et al.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2012)
ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer
Irene K. Guttilla et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia
Georg Aue et al.
BLOOD (2011)
Pattern of MHC class I and immune proteasome expression in Walker 256 tumor during growth and regression in Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis
Liudmila A. Zakharova et al.
CELLULAR IMMUNOLOGY (2011)
MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer
Cathy A. Andorfer et al.
TRENDS IN MOLECULAR MEDICINE (2011)
The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes
Andrew M. Pickering et al.
BIOCHEMICAL JOURNAL (2010)
The proteasome: Overview of structure and functions
Keiji Tanaka
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
p53 represses c-Myc through induction of the tumor suppressor miR-145
Mohit Sachdeva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The UPS: a promising target for breast cancer treatment
Ko Sato et al.
BMC BIOCHEMISTRY (2008)
Implications of applied research for prognosis and therapy of breast cancer
M. F. Barginear et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Multiple Forms of Proteasomes and their Role in Tumor Fate
Natalia Sharova et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2008)
Widespread microRNA repression by Myc contributes to tumorigenesis
Tsung-Cheng Chang et al.
NATURE GENETICS (2008)
Breast cancer progression: insights into multifaceted matrix metalloproteinases
Vincent Chabottaux et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics
Shishan Deng et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Proteasome-regulated ERBB2 and estrogen receptor pathways in breast cancer
Corina Marx et al.
MOLECULAR PHARMACOLOGY (2007)
International Union of Pharmacology.: LXIV.: Estrogen receptors
Karin Dahlman-Wright et al.
PHARMACOLOGICAL REVIEWS (2006)
Exclusion of immune proteasomes from mouse ascitic carcinoma Krebs-II cells
T. M. Astakhova et al.
BIOLOGY BULLETIN (2006)
Upregulation of immunoproteasomes by nitric oxide: Potential antioxidative mechanism in endothelial cells
S Kotamraju et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue
L Chen et al.
CANCER RESEARCH (2005)
Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples
I Cruz et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Multiple forms of proteasomes and approaches to their separation
EB Abramova et al.
BIOLOGY BULLETIN (2004)
Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor
Y Tateishi et al.
EMBO JOURNAL (2004)
The proteasome: Destroy to live
EB Abramova et al.
MOLECULAR BIOLOGY (2002)
The structure of the mammalian 20S proteasome at 2.75 Å resolution
M Unno et al.
STRUCTURE (2002)